Packaging Digest is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Packaging Design

Easy-Open Pharmaceutical Package Ensures Proper Dosing

Image courtesy of Ritedose Corp. Ritedose-suredose-mockup-ftd.jpg
A new single-dose, blow-fill-seal ampoule for generic liquid medications from Ritedose Corp. reduces the risk of spills and contamination.

Sterile pharmaceutical manufacturer Ritedose Corp. is debuting three of its most popular liquid drugs in a new, single-dose, blow-fill-seal container. The SuredoseRx dispensing device will replace the drugs’ current unit-dose cups, allowing end users better control when administering medications.

Traditionally, single-dose liquid medications are supplied in small, foil-lidded plastic cups that require the seal to be removed manually. This format can result in accidental spillage, compromising the dosage.

SuredoseRx ampoules are made of low-density polyethylene, chosen for its ease of machinability, and over-wrapped to maintain product stability. Each dose is individually bar-coded for ease of use in a hospital or clinical setting. After opening the pouch, the user removes the ampoule and twists off the cap to administer the liquid orally. Medication is released only when the ampoule is squeezed, thereby reducing spills. The design also allows for less spillage if the ampoule is dropped.

The concept for SuredoseRx began in a hospital room where president and CEO Jody Chastain’s wife was being treated for cancer. Chastain watched as a nurse struggled to remove the lid off a medication cup, finally resorting to scissors to cup the lid open.

“That one act immediately compromised the drug my wife was supposed to take,” he says. “I asked the nurse to get another cup.”

SuredoseRx is available in 5-, 10-, and 15-milliliter doses. The dispensing device will launch with three of the company’s generic drugs in the first quarter of 2022, followed by rollouts of other liquid medications.

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish